Boston Scientific Closes Acquisition of Silk Road Medical, Inc.

Boston Scientific Corporation (NYSE: BSX) announces the close of its acquisition of Silk Road Medical, Inc. (Nasdaq: SILK), a medical device company that pioneered a new approach for stroke prevention and the treatment of carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (TCAR). The acquisition includes a purchase price of $27.50 per share, reflecting an enterprise value of approximately $1.18 billion.

Read the full article: Boston Scientific Closes Acquisition of Silk Road Medical, Inc. //

Source: https://news.bostonscientific.com/2024-09-17-Boston-Scientific-Closes-Acquisition-of-Silk-Road-Medical,-Inc

Scroll to Top